Parkwood LLC Novavax Inc Transaction History

Parkwood LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $361,856 - $750,942	-9,974 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $212,467 - $435,416	3,047 Added 43.99%	9,974 $735,000
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $12,514 - $20,271	93 Added 1.36%	6,927 $991,000
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $672,617 - $1.02 Million	-3,783 Reduced 35.63%	6,834 $1.42 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $661,023 - $1.41 Million	5,463 Added 106.0%	10,617 $2.25 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $42,141 - $119,333	-373 Reduced 6.75%	5,154 $934,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $435,195 - $771,016	5,527 New	5,527 $616,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.